SEARCH

SEARCH BY CITATION

References

  • Arundine M. and Tymianski M. (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657668.
  • Barone F. C., Irving E. A., Ray A. M. et al. (2001a) Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev. 21, 129145.
  • Barone F. C., Irving E. A., Ray A. M. et al. (2001b) SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J. Pharmacol. Exp. Ther. 296, 312321.
  • Berridge M. J., Lipp P. and Bootman M. D. (2000) The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 1121.
  • Bickler P. E. and Fahlman C. S. (2004) Moderate increases in intracellular calcium activate neuroprotective signals in hippocampal neurons. Neuroscience 127, 673683.
  • Bolshakov V. Y., Carboni L., Cobb M. H., Siegelbaum S. A. and Belardetti F. (2000) Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses. Nat. Neurosci. 3, 11071112.
  • Boulanger L. M., Lombroso P. J., Raghunathan A., During M. J., Wahle P. and Naegele J. R. (1995) Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J. Neurosci. 15, 15321544.
  • Braithwaite S. P., Xu J., Leung J., Urfer R., Nikolich K., Oksenberg D., Lombroso P. J. and Shamloo M. (2008) Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemia. Eur. J. Neurosci. 27, 24442452.
  • Bult A., Zhao F., Dirkx Jr. R., Raghunathan A., Solimena M. and Lombroso P. J. (1997) STEP: a family of brain-enriched PTPs. Alternative splicing produces transmembrane, cytosolic and truncated isoforms. Eur. J. Cell Biol. 72, 337344.
  • Cao J., Viholainen J. I., Dart C., Warwick H. K., Leyland M. L. and Courtney M. J. (2005) The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J. Cell Biol. 168, 117126.
  • Chen Q. X., Perkins K. L., Choi D. W. and Wong R. K. (1997) Secondary activation of a cation conductance is responsible for NMDA toxicity in acutely isolated hippocampal neurons. J. Neurosci. 17, 40324036.
  • Chen W. G., Chang Q., Lin Y., Meissner A., West A. E., Griffith E. C., Jaenisch R. and Greenberg M. E. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (New York, NY) 302, 885889.
  • Cheng A., Wang S., Yang D., Xiao R. and Mattson M. P. (2003) Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J. Biol. Chem. 278, 75917599.
  • Choi D. W. and Rothman S. M. (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171182.
  • Dirnagl U., Iadecola C. and Moskowitz M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391397.
  • Gisabella B., Rowan M. J. and Anwyl R. (2003) Mechanisms underlying the inhibition of long-term potentiation by preconditioning stimulation in the hippocampus in vitro. Neuroscience 121, 297305.
  • Grabb M. C. and Choi D. W. (1999) Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J. Neurosci. 19, 16571662.
  • Haelewyn B., Alix P., Maubert E. and Abraini J. H. (2008) NMDA-induced striatal brain damage and time-dependence reliability of thionin staining in rats. J. Neurosci. Methods 168, 479482.
  • Horstmann S., Kahle P. J. and Borasio G. D. (1998) Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J. Neurosci. Res. 52, 483490.
  • Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S. and Ross M. E. (2001) Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl Acad. Sci. USA 98, 12941299.
  • Ingram A. J., James L., Thai K., Ly H., Cai L. and Scholey J. W. (2000) Nitric oxide modulates mechanical strain-induced activation of p38 MAPK in mesangial cells. Am. J. Physiol. Renal Physiol. 279, F243F251.
  • Kawasaki H., Morooka T., Shimohama S., Kimura J., Hirano T., Gotoh Y. and Nishida E. (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272, 1851818521.
  • Kim M. J., Dunah A. W., Wang Y. T. and Sheng M. (2005) Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46, 745760.
  • Kohr G. (2006) NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 326, 439446.
  • Kumar S., Boehm J. and Lee J. C. (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2, 717726.
  • Lipton S. A. and Rosenberg P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Eng. J. Med. 330, 613622.
  • Liu Y., Wong T. P., Aarts M. et al. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 28462857.
  • Luo J., Wang Y., Yasuda R. P., Dunah A. W. and Wolfe B. B. (1997) The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol. Pharmacol. 51, 7986.
  • Moolwaney A. S. and Igwe O. J. (2005) Regulation of the cyclooxygenase-2 system by interleukin-1beta through mitogen-activated protein kinase signaling pathways: a comparative study of human neuroglioma and neuroblastoma cells. Brain Res. Mol. Brain Res. 137, 202212.
  • Mottet D., Michel G., Renard P., Ninane N., Raes M. and Michiels C. (2003) Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J. Cell. Physiol. 194, 3044.
  • Mukherjee P. K., DeCoster M. A., Campbell F. Z., Davis R. J. and Bazan N. G. (1999) Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death. J. Biol. Chem. 274, 64936498.
  • Murray B., Alessandrini A., Cole A. J., Yee A. G. and Furshpan E. J. (1998) Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc. Natl Acad. Sci. USA 95, 1197511980.
  • Nguyen T. H., Liu J. and Lombroso P. J. (2002) Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. J. Biol. Chem. 277, 2427424279.
  • Nito C., Kamada H., Endo H., Niizuma K., Myer D. J. and Chan P. H. (2008) Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J. Cereb. Blood Flow Metab. 28, 16861696.
  • Park J. G., Yuk Y., Rhim H., Yi S. Y. and Yoo Y. S. (2002) Role of p38 MAPK in the regulation of apoptosis signaling induced by TNF-alpha in differentiated PC12 cells. J. Biochem. Mol. Biol. 35, 267272.
  • Paul S. and Connor J. (2010) NR2B-NMDA receptor mediated increases in intracellular Ca2+ concentration regulate the tyrosine phosphatase, STEP, and ERK MAP kinase signaling. J. Neurochem. 114, 11071118.
  • Paul S., Snyder G. L., Yokakura H., Picciotto M. R., Nairn A. C. and Lombroso P. J. (2000) The Dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. J. Neurosci. 20, 56305638.
  • Paul S., Nairn A. C., Wang P. and Lombroso P. J. (2003) NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat. Neurosci. 6, 3442.
  • Paul S., Olausson P., Venkitaramani D. V. et al. (2007) The striatal-enriched protein tyrosine phosphatase gates long-term potentiation and fear memory in the lateral amygdala. Biol. Psychiatry 61, 10491061.
  • Paxinos G. and Watson C. (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
  • Poddar R. and Paul S. (2009) Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J. Neurochem. 110, 10951106.
  • Pulido R., Zuniga A. and Ullrich A. (1998) PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17, 73377350.
  • Raval A. P., Dave K. R., Mochly-Rosen D., Sick T. J. and Perez-Pinzon M. A. (2003) Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J. Neurosci. 23, 384391.
  • Rockwell P., Martinez J., Papa L. and Gomes E. (2004) Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell. Signal. 16, 343353.
  • Rodrigues S. M., Schafe G. E. and LeDoux J. E. (2001) Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J. Neurosci. 21, 68896896.
  • Runden E., Seglen P. O., Haug F. M., Ottersen O. P., Wieloch T., Shamloo M. and Laake J. H. (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J. Neurosci. 18, 72967305.
  • Semenov D. G., Samoilov M. O. and Lazarewicz J. W. (2002) Calcium transients in the model of rapidly induced anoxic tolerance in rat cortical slices: involvement of NMDA receptors. Neuro-Signals 11, 329335.
  • Snyder E. M., Nong Y., Almeida C. G. et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 10511058.
  • Stanciu M. and DeFranco D. B. (2002) Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J. Biol. Chem. 277, 40104017.
  • Tauskela J. S. and Morley P. (2004) On the role of Ca2+ in cerebral ischemic preconditioning. Cell Calcium 36, 313322.
  • Thomas G. M. and Huganir R. L. (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173183.
  • Thompson R. J., Jackson M. F., Olah M. E., Rungta R. L., Hines D. J., Beazely M. A., MacDonald J. F. and MacVicar B. A. (2008) Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science (New York, NY) 322, 15551559.
  • Tovar K. R. and Westbrook G. L. (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19, 41804188.
  • Tu W., Xu X., Peng L. et al. (2010) DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140, 222234.
  • Walker D. L. and Davis M. (2008) Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learn. Mem. (Cold Spring Harbor, NY) 15, 6774.
  • Wang Q., Walsh D. M., Rowan M. J., Selkoe D. J. and Anwyl R. (2004) Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 24, 33703378.
  • Waxman E. A. and Lynch D. R. (2005) N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. J. Biol. Chem. 280, 2932229333.
  • Xu J., Kurup P., Zhang Y., Goebel-Goody S. M., Wu P. H., Hawasli A. H., Baum M. L., Bibb J. A. and Lombroso P. J. (2009) Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J. Neurosci. 29, 93309343.
  • Zhao M. G., Toyoda H., Lee Y. S. et al. (2005) Roles of NMDA NR2B subtype receptor in pre long-term potentiation and contextual fear memory. Neuron 47, 859872.
  • Zhu J. J., Qin Y., Zhao M., Van Aelst L. and Malinow R. (2002) Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell 110, 443455.